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Recent animal and human studies have under-
scored the strong influence of genetic, epi-
genetic, and physiologic factors in defining
susceptibility of the immune system to
methylmercury (MeHg) and ethylmercury
(EtHg) (Havarinasab and Hultman 2005;
Lawler et al. 2004; Silbergeld et al. 2005).
Immune dysregulation triggered by organic
mercury can include suppression, stimulation,
loss of tolerance, and generation of auto-
antibodies. Therefore, the pattern of immuno-
toxicity induced by organic mercury is likely
to depend not only on the chemical form,
timing, and dose to which an individual is
exposed but also on susceptibility factors that
are poorly understood at present. Thus, signif-
icant attention is currently focused on identi-
fying which types of immune cells and
biomolecules are critical targets of low-level
organic mercury and their functional conse-
quences on overall immune status.
Sodium ethylmercurithiosalicylate (thi-
merosal; THI) is an EtHg-containing com-
pound used to preserve cosmetics, blood
products, and vaccines and is also used exper-
imentally to induce calcium (Ca2+) release
from microsomal [endoplasmic reticulum/
sarcoplasmic reticulum (ER/SR)] stores in
intact cells. THI toxicity is due to the EtHg
moiety. THI and EtHg toxicity in humans
consist of a few cases of accidental high-dose
poisoning (Cinca et al. 1980; Damluji 1962;
Zhang 1984). Attention has been focused on
THI in vaccines, where it is used as a preserv-
ative for multiuse formulations. THI was
withdrawn from pediatric vaccines starting in
1999 (Centers for Disease Control and
Prevention 1999) over concerns that organic
mercury is a known neurodevelopmental tox-
icant. Nevertheless, THI is still used in
influenza, diphtheria toxoid, diphtheria tox-
oid and acellular pertussis (DTaP), and
tetanus toxoid vaccines. The hypothesis that
THI can cause neurodevelopmental disorders
was tested by injecting THI and THI-con-
taining vaccines into inbred strains of young
mice (Hornig et al. 2004). Growth, behav-
ioral, and histologic abnormalities in the
brains of the autoimmune susceptible strain
(SJL) were recorded after administration of
THI or THI plus vaccine. Autoimmune-
resistant strains (C57BL/6, BALB/c) did not
display any of the abnormalities, suggesting a
strong influence of inherent immune status
and the neurodevelopmental toxicity of THI.
We hypothesized that especially sensitive
targets of THI-mediated immune dysregu-
lation are dendritic cells (DCs), whose func-
tion is to acquire antigens derived from self or
nonself sources and efficiently present them
to naive and resting T cells (Banchereau and
Steinman 1998). This hypothesis stems from
the fact that ambient oxygen (O2) tension or
thiol concentration directly influences DC
secretion of interferon-γ (IFN-γ) and inter-
leukin-12 (IL-12) (Murata et al. 2002),
enhances expression of FcεR1, the high afﬁn-
ity receptor for IgE (Novak et al. 2002), and
regulates surface class II major histo-
compatibility complex (MHC) expression
(Goth et al. 2006) in vitro. In this regard,
Ca2+ contributes essential signals for DC
function and maturation. Differentiation
(Bagley et al. 2004), pro-inflammatory
cytokine secretion (Gardella et al. 2000),
apoptotic cell phagocytosis (Poggi et al.
1998), and migrational responsiveness to
purine nucleotides or chemokines (Partida-
Sanchez et al. 2004; Scandella et al. 2004) are
Ca2+-dependent processes. DCs rely on
changes in intracellular redox state and Ca2+
signals for proper development and function,
but the relationship between these signaling
systems in DCs is unclear.
THI contains an oxidized mercury atom
(Hg2+) whose redox properties can enhance
the activity of the inositol 1,4,5-trisphosphate
receptor (IP3R) and ryanodine receptor
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Dendritic cells (DCs), a rare cell type widely distributed in the soma, are potent antigen-presenting
cells that initiate primary immune responses. DCs rely on intracellular redox state and calcium
(Ca2+) signals for proper development and function, but the relationship between these two signal-
ing systems is unclear. Thimerosal (THI) is a mercurial used to preserve vaccines and consumer
products, and is used experimentally to induce Ca2+ release from microsomal stores. We tested
adenosine triphosphate (ATP)-mediated Ca2+ responses of DCs transiently exposed to nanomolar
THI. Transcriptional and immunocytochemical analyses show that murine myeloid immature DCs
(IDCs) and mature DCs (MDCs) express inositol 1,4,5-trisphosphate receptor (IP3R) and ryanodine
receptor (RyR) Ca2+ channels, known targets of THI. IDCs express the RyR1 isoform in a punctate
distribution that is densest near plasma membranes and within dendritic processes, whereas IP3Rs
are more generally distributed. RyR1 positively and negatively regulates purinergic signaling because
ryanodine (Ry) blockade a) recruited 80% more ATP responders, b) shortened ATP-mediated Ca2+
transients > 2-fold, and c) produced a delayed and persistent rise (≥ 2-fold) in baseline Ca2+. THI
(100 nM, 5 min) recruited more ATP responders, shortened the ATP-mediated Ca2+ transient
(≥ 1.4-fold), and produced a delayed rise (≥ 3-fold) in the Ca2+ baseline, mimicking Ry. THI and
Ry, in combination, produced additive effects leading to uncoupling of IP3R and RyR1 signals. THI
altered ATP-mediated interleukin-6 secretion, initially enhancing the rate of cytokine secretion but
suppressing cytokine secretion overall in DCs. DCs are exquisitely sensitive to THI, with one
mechanism involving the uncoupling of positive and negative regulation of Ca2+ signals contributed
by RyR1. Key words: calcium, calcium channel, dendritic cell, ethyl mercury, immunotoxicity, inter-
leukin-6, organic mercury, redox, thimerosal. Environ Health Perspect 114:1083–1091 (2006).
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(Kaplin et al. 1994; Pessah et al. 2002). THI
elicits Ca2+ release from ER/SR stores in
lymphocytes (Bultynck et al. 2004) and ER/SR
microsomes by targeting the IP3R and RyR
(Abramson et al. 1995; Kaplin et al. 1994).
THI-treated, monocyte-derived DCs failed to
or only minimally phosphorylated STAT (sig-
nal transducer and activator of transcription)
proteins 1, 3, 4, and 6, implying that the JAK
(janus kinase) signaling pathway and, by exten-
sion, cytokine receptors are bypassed in the sen-
sitization phase induced by THI (Valk et al.
2002). DCs express several classes of Ca2+ chan-
nel proteins that mediate Ca2+ signals. DCs
express store-operated Ca2+ channels (Hsu et al.
2001) and IP3Rs that regulate release of Ca2+
from ER/SR stores in response to adenosine
triphosphate (ATP) (Schnurr et al. 2003) and
chemokines (Scandella et al. 2004). Immature
DCs (IDCs) express message for one of three
genetic forms of the RyR, the RyR1 (Hsu et al.
2001; O’Connell et al. 2002). The inﬂuence of
THI and its metabolites EtHg and thiosalicylic
acid (TSA) on Ca2+ signaling and activation of
DCs remain unexplored.
To study how THI and EtHg influence
Ca2+-dependent DC functions, we generated
and tested murine DCs under normoxia (5%
O2 vol/vol) and omitted 2-mercaptoethanol
(2-Me) from the culture medium. In this arti-
cle we report that DCs primarily express the
type 1 isoform of the IP3R and RyR ER/SR
Ca2+ channels, known targets of THI. THI
and ryanodine (Ry) each block early positive
contributions of the RyR1 to ATP-induced
Ca2+ transients and uncouple inhibitory feed-
back, indicating a common mechanism. The
consequences of THI upon ATP-induced IL-6
production, a Ca2+-dependent process, were
examined. THI initially enhanced the IL-6
secretion rate, but ultimately suppressed its
accumulation. DCs are exquisitely sensitive to
THI, with one prominent mechanism involv-
ing the uncoupling of positive and negative
regulation of Ca2+ signals contributed by
RyR1.
Materials and Methods
Chemicals and antibodies. THI (USP grade)
and its metabolite TSA, propidium iodide
(PI), diethylpyrocarbonate, and Na2ATP were
purchased from Sigma (St. Louis, MO). We
purchased fibronectin (bovine plasma) from
Calbiochem (San Diego, CA) and ethyl-
mercuric chloride (EtHgCl) from ICN (Costa
Mesa, CA). Recombinant murine granulo-
cyte/macrophage colony stimulating factor
(GM-CSF) was purchased from Sigma or
R&D Systems (Minneapolis, MN), as were
murine IL-6 ELISA kits. Antibodies (BD-
Pharmingen, San Diego, CA) are as follows
(clone name): class II MHC-biotin (2G9),
CD11c-APC (HL3), CD16/32 (2.4G2), and
hamster immunoglobulin. Anti-RyR mono-
clonal antibody 34C (recognizes types 1 and 3)
was purchased from the Developmental
Studies Hybridoma Bank (Iowa City, IA).
Anti-IP3R and anti-IP3R1 polyclonal antibod-
ies were purchased from Chemicon (Temecula,
CA). Prolong Antifade, Fura-2 AM, Fluo-4
AM, Alexa 488–conjugated goat anti-mouse
IgG antibody, Alexa 488–conjugated goat
anti-rabbit IgG antibody, and Alexa 647–
conjugated goat anti-rabbit IgG antibody
were purchased from Invitrogen (Carlsbad,
CA). 7-Aminoactinomycin D (7AAD) was
purchased from Calbiochem. A fluorescent
terminal deoxynucleotidyl transferase (TdT)
labeling kit was purchased from Promega
(Madison, WI).
Cell culture. Female C57BL/6J mice
6–8 weeks of age were purchased from JAX
West, Inc. (Davis, CA), treated humanely and
with regard for alleviation of suffering, and
euthanized in accordance with a protocol
approved by the University of California–Davis
Animal Resources Service. Bone-marrow–
derived DCs were generated by modifying a
protocol (Lutz et al. 1999), using normoxia
(5% O2 vol/vol), and omitting 50 μM 2-Me
from the culture medium (Goth et al. 2006).
R10 medium was RPMI 1640 (Invitrogen)
with 10% fetal bovine serum (FBS; Hyclone,
Logan, UT), 2 mM L-glutamine, 2 mM
sodium pyruvate, 100 IU/mL penicillin, and
10 μg/mL streptomycin. Cultures were main-
tained at 37°C in a Thermo Forma model
3130 incubator (Thermo Forma, Marietta,
OH) equipped with a CO2 and fuel-cell O2
monitor and N2 and CO2 gas supplies. CO2
was set to 5% vol/vol, and O2 to 5% vol/vol,
and were periodically veriﬁed using Fyrite gas
analyzers (Bacharach Inc., New Kensington,
PA).
DC cytometric flow sorting and analysis.
Cells were ﬂow sorted between culture days 6
and 10. A detailed description of our cell
preparation for ﬂow cytometry has been pub-
lished (Goth et al. 2006). Brieﬂy, nonadherent
cells were preblocked with 2.4G2 monoclonal
antibody (1.0 μg/mL) and hamster IgG
(0.25 μg/mL) for 10 min. Fluorescent anti-
class II MHC (0.1 μg/mL) and anti-CD11c
(0.3 μg/mL) monoclonal antibodies were
added and allowed to bind for 15 min. After
washing with 2% FBS in phosphate-buffered
saline (PBS), cells were aseptically sorted on a
MoFlo cytometer (Cytometric, Fort Collins,
CO). Single-stained and unstained controls
were used to deﬁne sorting gates and to adjust
compensation. CD11c-positive cells were con-
sidered DCs and graded as IDCs or mature
DCs (MDCs) depending on their class II
MHC expression. We routinely obtained
≥ 85% purities of sorted IDC and MDC sub-
sets. PI was added to a ﬁnal concentration of
0.5 μg/mL before sorting or before analysis on
a FACScan ﬂow cytometric analyzer (Becton
Dickinson, Palo Alto, CA) to detect dead cells.
DC treatment. THI, EtHgCl, and TSA
solutions were dissolved in sodium carbonate
using borosilicate glass pipettes and tubes.
Dilutions were made in R10 and used within
1 hr. DCs (1–2 × 106 cells/mL) were aliquoted
into perfluorocarbon tissue culture vials or
96-well format plates (Savillex, Minnetonka,
MN). R10 or medium containing THI,
EtHgCl, TSA, or lipopolysaccharide (LPS) (to
1 μg/mL) was added, and cells were placed in a
37°C incubator.
DC transcriptome analysis. Total RNA was
isolated from sorted DCs using Trizol Reagent
(Molecular Research Center, Cincinnati,
OH) according to the manufacturer’s recom-
mended procedure. DCs were resuspended to
1 × 106 cell/mL in R10 media, plated in per-
fluorocarbon containers, and incubated for
20 hr. Biotinylated cRNA was synthesized
from 5 μg of total cellular RNA according to
the protocol published by Affymetrix Inc.
(Affymetrix 2004). Fragmented, labeled cRNA
was hybridized onto Affymetrix mouse 430A
or 430 2.0 GeneChip arrays. Microarrays were
hybridized 16 hr at 45°C, stained, and washed
according to an Affymetrix protocol (EukGE-
WS2v4; Affymetrix 2004). Fluorescence inten-
sity was measured with a scanner equipped
with Affymetrix Microarray Analysis Suite ver-
sion 5.0. The average intensity for each array
was normalized by scaling to a target intensity
value of 125, allowing comparison between
arrays. Individual transcripts are represented by
perfect-match probes in conjunction with a
corresponding set of mismatch probes. A tran-
script is called present if the average intensity
value of perfect-match cells is ≥ 1.5 times
greater than the average intensity of mismatch
cells, and the average intensity difference
between perfect-match and mismatch cells is
four or more times the experimental noise.
Poorly performing probes (where the ratio
between the average intensity of mismatch cells
and perfect-match cells is four or more times
the experimental noise) were not included in
the analysis. RNA from three independent cul-
tures was analyzed on GeneChips (i.e., three
GeneChips per treatment were analyzed).
Immunocytoﬂuorescence of calcium chan-
nels. DCs were washed in 1% bovine serum
albumin (BSA) in PBS, centrifuged onto glass
slides using a Cytofuge2 (Statspin, Norwood,
MA), air dried, ﬁxed with 4% paraformalde-
hyde in PBS for 20 min at 4°C, and then per-
meabilized with three washes of 0.2%
Tween-20 in PBS (TPBS). Nonspeciﬁc bind-
ing was blocked with goat IgG (50 μg/mL).
Cells were incubated with primary antibody
(dilutions were 1:20 34C and 1:100 anti-IP3R
and IP3R1 polyclonal antibodies in TPBS) for
1 hr. Blocking peptide for the IP3R1 antibody
was used at the manufacturer’s suggested
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Alexa 647–conjugated anti-mouse and anti-
rabbit secondary antibodies were diluted
1:1,000 in TPBS and allowed to bind 1 hr.
Cells were washed with TPBS and then with
PBS. After mounting with Prolong Antifade
plus 40 μg/mL 7AAD, DCs were visualized for
immunoﬂuorescence using an MRC 600 laser
scanning confocal microscope (Bio-Rad,
Richmond, CA). Confocal immunopheno-
typing was performed on two separate cultures.
TdT assay. IDCs were treated with
500 nM TSA, THI, or medium for 20 hr as
described above. Cells were then washed twice
with ice-cold PBS and fixed with 4%
paraformaldehyde in PBS for 20 min on ice.
Cells were washed in 1% BSA in PBS and
resuspended to 0.5 × 106 cells/mL in 1% BSA
in PBS; cell aliquots were then spun onto
microscope slides. Slides were air dried at least
2 hr and then immersed in 4% diethylpyro-
carbonate:ethanol prechilled to –20°C for
30 min to stop endogenous nuclease activity.
After washing twice with PBS, cells were
processed for DNA strand end-labeling accord-
ing to the protocol supplied by the kit manu-
facturer (Promega). After TdT labeling, nuclei
were counterstained with 1 μg/mL PI in water
for 15 min before mounting in Prolong
Antifade for confocal imaging.
[3H]Ryanodine binding analysis. High-
affinity binding of [3H]ryanodine ([3H]Ry;
56 or 50 Ci/mmol; PerkinElmer, Boston,
MA) to rabbit skeletal microsomes enriched in
RyR1 was performed as previously described
(Pessah et al. 1987). Nonspeciﬁc binding was
determined by including 1,000-fold unlabeled
Ry. Data were reported in picomoles of bound
Ry per milligram of protein.
IL-6 assays. IDCs were pulsed with
100 nM THI or TSA for 20 min, pelleted,
supernatant aspirated, and resuspended to
2 × 107/mL; 0.05 mL of the cell suspension
was aliquoted per well into a perﬂuorocarbon
96-well plate, and 0.05 mL ATP (0, 0.2, 2, or
20 μM final) was added per well. Medium
and LPS (1 μg/mL ﬁnal) cells received no pre-
treatment. Supernatants for IL-6 ELISA were
collected 20 hr later from the top portion of
the cultures. IL-6 concentrations were inter-
polated from the linear response range of the
cytokine standard; minimum sensitivity was
7 pg/mL.
Calcium imaging. IDCs were resuspended
in R10 supplemented with 5 ng/mL recombi-
nant murine GM-CSF to 0.5 × 106/mL;
0.5 mL was plated overnight onto ﬁbronectin-
coated glass coverslips. The next day, cells were
labeled with 5 μM Fura-2 AM or Fluo-4 AM
for 20 min. Cells were washed with bathing
solution (130 mM NaCl, 4 mM KCl, 10 mM
HEPES, 10 mM glucose, 2 mM CaCl2, 2 mM
MgSO4, pH 7.3, with NaOH) and imaged
within 1 hr. Changes in cytoplasmic Ca2+ were
measured by emission at 510 nm (Fluo-4) or
ratioing emission at 510 nm with excitation
pair 340/380 nm (Fura-2) (Fessenden et al.
2003). Rapid perfusion of ATP and caffeine
was accomplished by a micropipette above the
cells being imaged (Automate, Oakland, CA).
Data analysis. Nonlinear curve fitting
analysis and one-way analysis of variance were
performed using Origin 6.0 (OriginLab
Corporation, Northampton, MA) software to
test for statistical signiﬁcance.
Results
Culturing murine bone marrow at physiologic
O2 tension (5% vol/vol) without 2-Me supple-
mentation generated myeloid IDCs and
MDCs with a similar yield, leukocyte marker
expression, and allostimulatory capacity as
DCs produced from cultures using ambient
(20%) O2 and 50 μM 2-Me (Goth et al.
2006). A representative flow cytometric dot
plot showing sorting gates for IDCs and
MDCs is shown in Supplemental Material,
Figure 1A (available online at http://www.
ehponline.org/docs/2006/8881/suppl.pdf).
RNAs extracted from sorted IDCs and MDCs
were analyzed using gene probe arrays. IDCs
and MDCs have a common lineage, and a
small number of changes in gene expression
occurred during maturation. Of this limited set
of genes, class II MHC mRNA expression is
down-regulated with maturation, whereas
CD86 message was up-regulated with matura-
tion (Table 1). Glyceraldehyde-3-phosphate
dehydrogenase (GADPH) was expressed at
similar levels in IDCs and MDCs (Table 1).
Both DC subsets express two Ca2+ channel
types that are targets of THI. Of the three IP3R
isoforms, IDCs and MDCs express message for
ITPR1 and ITPR3, the latter down-regulated
with maturation (Table 1). Of the three RyR
isoforms, RyR1 mRNA is present in both DC
subsets, RyR3 is expressed upon maturation,
and RyR2 is not expressed (Table 1). Because
the Ca2+ channel genes detected encode targets
of THI, we explored the distribution of the
proteins in IDCs using confocal microscopy.
IDCs express IP3R1 in a dense granular
distribution in a pattern consistent with target-
ing to ER membranes (Figure 1A,E). In con-
trast, intense RyR1 staining localizes near the
plasma membrane, and foci of protein extend
from the base into dendrites (Figure 1C,E,F).
IDCs lack detectable RyR1 within perinuclear
regions (Figure 1C,E,F). Cells stained with sec-
ondary antibody alone or with antibody-block-
ing peptide (IP3R1) had no detectable signal
(Figure 1B,D). The codistribution of RyR1
and IP3R was further examined using an anti-
RyR1 monoclonal antibody and a pan anti-
IP3R polyclonal antibody. The RyR1 is densely
localized within a narrow band at the cell
periphery and extends within dendrites
(Figure 1E,F), whereas IP3R extends to regions
lacking RyR1 (Figure 1E). The granular
appearance and distribution of IP3R protein in
IDCs did not change when visualized with an
isoform speciﬁc (IP3R1) or pan-IP3R antibody
(Figure 1A,E). The distribution of RyR pro-
teins in IDCs and MDCs (using a monoclonal
antibody speciﬁc for RyR1 and 3) were similar
(Figure 1G,H) despite the additional expres-
sion of RyR3 transcripts in MDC (Table 1).
Ca2+ responses of IDCs to the RyR ago-
nist caffeine were tested. Given the expression
of RyR1 within IDCs, and that MDCs
respond to caffeine (Schnurr et al. 2003), we
expected IDCs would respond to caffeine with
a rise in cytoplasmic Ca2+. Approximately
50% of IDCs responded to 20 mM caffeine
(Figure 2A). Because extracellular ATP
induces maturity in IDCs (la Sala et al. 2001,
2002; Schnurr et al. 2001) and intracellular
Ca2+ contributes an essential DC maturation
signal (Bagley et al. 2004), we decided to test
the ability of our IDCs to respond to extra-
cellular ATP. IDCs responded vigorously to a
brief (5 sec) application of ATP, the response
amplitude dose-dependent between 0.2 and
20 μM (Figure 2B). Therefore, ATP potently
elicits Ca2+ transients, likely mediated
through agonist actions on P2Y purinergic
nucleotide receptors expressed in IDCs (Idzko
et al. 2002). We next generated viability–dose
Nanomolar thimerosal dysregulates DC signaling
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Table 1. Mean signal intensities of Ca2+ channel and selected immune marker gene expression in bone-
marrow–derived IDCs and MDCs from C57BL/6 mice.
IDCs MDCs
Gene product (GenBank accession no.) Signala Call Signal Call
RyR1 (X83932.1) 99, 360, 178 P 59, 114, 107 P
RyR2 (NM_023868.1) 8, 2, 2 A 18, 6, 2 A
RyR3 (AV238793) 13, 3, 13 A 34, 75, 48 P
IP3R1 (NM_010585.1) 77, 148, 147 P 183, 178, 181 P
IP3R2 (NM_019923.1) 31, 23, 32 A 50, 27, 46 A
IP3R3 (NM_080553.1) 116, 128, 115 P 87, 95, 68 P
MHC class II H2-IAβ(M15848.1) 2,493, 4,467, 3,727 P 1,454, 2,340, 1,775 P
CD86 (NM_019388.1) 167, 399, 596 P 398, 721, 669 P
GADPH (NM_008084.1) 11,241, 4,761, 4,547 P 11,126, 4,635, 5,186 P
Abbreviations: A, transcript absent; P, transcript present. DCs were cultured without 2-Me at 5% O2; data are from three
independent DC cultures. GenBank data are available online (GenBank 2006).
aRelative RNA expression; individual values are given for three assays: the ﬁrst value is from hybridization to an Affymetrix
mouse 430A GeneChip array, and the second and third values are from hybridization to an Affymetrix 430 2.0 GeneChip array.survival curves for DCs exposed to THI and its
metabolites EtHg (from EtHgCl) and TSA
[chemical structures are shown in Supplemental
Material, Figure 1B (available online at http://
www.ehponline.org/docs/2006/8881/
suppl.pdf)].
Range-finding experiments determined
that a 20 hr exposure to 10 μM THI consis-
tently killed > 90% of DCs using ﬂow cytome-
try, judged by their increased permeability to
PI and decreased cell size [forward light scatter
(FSC); data not shown]. THI, EtHgCl, and
TSA were titrated from 50 nM to 10 μM,
IDC and MDC subsets were treated for 20 hr,
and cell PI permeability was measured by ﬂow
cytometry. Figure 3A and B shows that THI
and EtHgCl caused dose-dependent decreases
in DC viability compared with the TSA con-
trol. The viability dose–response curves for
THI and EtHgCl were the same within each
DC subset and were similar between the cell
subsets. IC50 (concentration that inhibits 50%)
values for the DC subsets treated with THI,
TSA, and EtHgCl are shown in Figure 3A
and B. DC death triggered by THI could be
mediated by apoptosis or primary necrosis,
because the FSC and PI uptake data acquired
20 hr posttreatment cannot distinguish
between the two possibilities. IDCs were
treated with medium alone, 500 nM TSA, or
500 nM THI for 20 hr and probed for DNA
strand breakage, an indicator of apoptosis
(Figure 3C,D,E, respectively). Only THI-
treated cells demonstrate both increased
2´-deoxyuridine 5´-triphosphate-fluorescein
isothiocyanate labeling and a corresponding
shrinkage in nuclear size (Figure 3E); death
from THI exposure is therefore likely to be an
apoptotic outcome. The action of THI and
EtHgCl upon RyR1 channels was further
explored by measuring [3H]Ry binding to
ER/SR membranes enriched in RyR1. THI
and EtHgCl inhibited the speciﬁc binding of
[3H]Ry to RyR1 (Figure 3F; IC50 = 562 and
501 nM).
Lymphocyte tolerance or immunity to an
antigen can be driven by IDCs or MDCs,
respectively (Steinman et al. 2005), and we
focused on characterizing the effects of THI
upon ATP-mediated Ca2+ signaling (a matu-
ration signal) in IDCs. THI can release Ca2+
from ER/SR stores by selectively enhancing
the activity of IP3R and RyR, and we exam-
ined its actions on ATP-mediated Ca2+ signal-
ing in IDC. ATP is an efﬁcacious activator of
DCs through its agonist actions on P2Y
purinergic nucleotide receptors (Idzko et al.
2002). P2Y receptors couple to Gαq protein
that initiates signal transduction events leading
to the hydrolysis of phosphatidylinositol
4,5-bisphosphate (PIP2) to IP3 and diacylglyc-
erol. IP3 in turn activates IP3R that mobilizes
Ca2+ from ER stores (Di Virgilio et al. 2001a,
2001b). IDCs challenged with two pulses of
20 μM ATP (5 sec each) 30 min apart (with
constant perfusion) produced Ca2+ transients
whose peak heights, baseline to peak rates, or
peak to baseline decays were not signiﬁcantly
different (Figure 4A). This indicates that the
concentration, duration, and frequency of the
ATP challenges did not desensitize the cell’s
capacity to respond, nor were they additive.
Perfusion of 50 nM THI after an initial
ATP test pulse (Figure 4B) did not induce a
Goth et al.
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Figure 1. DCs express IP3R and RyR Ca2+ channels. Abbreviations: Ab, antibody; mAb, monoclonal antibody. (A–D) IDCs labeled with anti-IP3R1 (A) or anti-RyR (C)
or with anti-IP3R1 plus blocking peptide (B) or fluorescent second-step Ab alone (D). Nuclei were counterstained with 7AAD; magnification, 100×.
(E and F) Merged images of RyR1 and IP3R (pan anti-IP3R) immunostaining in IDCs (E), and RyR1 and 7AAD nuclear staining (F); images were acquired at 100× with
2.5× digital magniﬁcation. (G and H) IDCs (G) and MDCs (H) stained for RyR; magniﬁcation, 40×. Bars = 10 µm.
Figure 2. IDCs respond to caffeine (CAF) and ATP. (A) IDCs were loaded with Fluo-4 or Fura-2 as described
in “Materials and Methods.” IDCs that responded to CAF (20 mM) also responded to 20 µM ATP, and cells
that failed to respond to ATP also did not respond to caffeine (data not shown). (B) The ATP response mag-
nitude (averaged trace of 20 cells shown) was dose dependent. (A) and (B) represent two independent
experiments.
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5rise in baseline Ca2+ in the 30 min of perfu-
sion that preceded the second ATP challenge.
In the presence of THI, the second ATP
pulse produced a baseline to Ca2+ peak height
comparable with that elicited by the ﬁrst ATP
challenge. However, the rate of decay of the
response peak was significantly slowed by
THI compared with control cells. THI also
induced a sustained elevation in the 8 min of
trace recording in intracellular Ca2+ after ATP
withdrawal. DCs exposed to 100 nM THI
(Figure 4C) showed a gradual rise in resting
Ca2+. Although cells responded to a second
ATP challenge, decay of the response was sig-
nificantly slower and incomplete compared
with DCs exposed to 50 nM THI. After
withdrawal of ATP from the perfusion
medium, a more pronounced slow rise of
intracellular Ca2+ concentration was seen and
remained elevated for the duration of the
measurement. Some DCs tested with 20 μM
ATP failed to show detectable responses.
However these “ATP-resistant” cells invariably
responded vigorously to ATP after exposure to
50 nM THI for 30 min (data not shown). We
next dissected the ATP-mediated calcium wave
in DCs using pharmacologic agents known to
modify components of Ca2+ signaling.
ATP generated a stereotyped Ca2+ tran-
sient having a time to peak of 16.1 ± 2.6 sec
and a decay time of 106 ± 2.6 sec (Figure 5A,
top trace). To test the RyR1’s contribution to
ATP-mediated Ca2+ transients, IDCs were pre-
treated 4 hr with 100 μM Ry, which irre-
versibly locks the RyR in a nonconducting
conformation (Buck et al. 1992; Zimanyi et al.
1992). ATP-challenged Ry-treated cells pro-
duced transients whose time to peak did not
significantly differ from control (Figure 5A,
second trace; Figure 5B). However, after ATP
withdrawal, the recovery time to baseline was
> 2-fold (p < 0.01) faster (Figure 5A, second
trace; Figure 5C) and showed a delayed and
persistent rise (p = 0.036) in baseline Ca2+
after triggering (Figure 5A, second trace;
Figure 5D). A 5 min THI (100 nM) pre-
exposure mimicked the effects of Ry. When
challenged with ATP, the rise time remained
unchanged (Figure 5B), but the Ca2+ tran-
sient was shortened > 1.5-fold (p = 0.05;
Figure 5C) and the delayed rise in Ca2+ base-
line was prominent (p = 0.02) (Figure 5A,
third trace; Figure 5D).
The effects of THI and Ry in combination
were nearly additive (Figure 5A, fourth trace;
Figure 5C,D), suggesting a common mecha-
nism targeting RyR1 function. THI and Ry
alone or combined increased the number of
IDCs responding to ATP 1.5- to 1.8-fold
compared with control (p < 0.05; Figure 5E).
THI’s actions on IDCs Ca2+ signaling were
Nanomolar thimerosal dysregulates DC signaling
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Figure 3. Dose–response survival curves and IC50 values for IDCs and MDCs treated 20 hr with THI, EtHgCl,
or TSA. (A and B) Survival curves plotting percent PI-negative cells versus medium control (as 100%) for
IDCs (A) and MDCs (B). (C–E) TdT DNA strand labeling and confocal microscopy of IDCs treated with
medium (C), 500 nM TSA (D), or 500 nM THI (E) for 20 hr. Nuclei with strand breakage stain green; all nuclei
are counterstained red with PI. Note the small and round apoptotic morphology of the THI-treated nuclei
compared with controls. Original magniﬁcation, 40×; bars = 10 µm. (F) THI and EtHgCl inhibit [3H]Ry binding
to RyR1 high-affinity sites. Receptor binding analysis was performed as described in “Materials and
Methods”; IC10, IC20, and IC50 values were determined by nonlinear curve ﬁtting. TSA had no effect at the
highest concentration tested. Data shown are the average of two independent experiments.
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Figure 4. Ca2+ transients elicited in IDCs by ATP
before and after 20 min exposure (bars beneath
traces) to buffer (A), 50 nM THI (B), or 100 nM
THI (C). DCs were given 20 µM ATP (5 sec, first
arrow) 1 min after the start of trace recording. The
cells were challenged a second time with ATP, and
traces were recorded 8 min. Thin horizontal lines
indicate the initial baseline. R340/380 ratiometric data
were acquired every 2 sec. Traces are the mean ±
SE and represent two experiments.not seen with TSA; therefore, they were medi-
ated by organic mercury (data not shown).
These results (Figures 4, 5) indicate that as lit-
tle as 50–100 nM THI in a short time span
(5–30 min) potentiates agonist-mediated Ca2+
signaling events in DCs that primarily mani-
fest as a prolonged elevation in intracellular
Ca2+. DCs are arguably the most sensitive tar-
get cell for THI identified to date, and this
sensitivity to oxidative insult may reflect a
unique manner in which they generate and
use Ca2+ signals in response to a changing
redox environment.
Increased intracellular Ca2+ induced by
inhibitors of the ER/SR Ca2+-ATPase is asso-
ciated with the rapid secretion of macrophage
IL-6 (Bost and Mason 1995). DCs produce
IL-6 in response to IL-1β, tumor necrosis fac-
tor-α, or LPS, and other myeloid cells secrete
IL-6 in response to ATP (Shigemoto-Mogami
et al. 2001). We hypothesized that THI-
induced uncoupling of ATP-mediated Ca2+
signaling would disrupt IL-6 secretion. IDCs
were pretreated with 100 nM THI or TSA
and challenged with graded concentrations of
ATP, and secreted IL-6 was measured.
Figure 6A shows that IDCs pretreated with
THI or TSA alone secreted low levels of IL-6
that did not significantly differ from the
medium control. LPS, which induces IL-6
synthesis by non-Ca2+-dependent pathways,
induced a large increase in IL-6. All three ATP
concentrations induced comparable amounts
of IL-6 by the TSA-pretreated DCs. By 20 hr,
these IL-6 concentrations were equal to the
LPS-treated control. Pretreating IDCs with
THI and challenging with ATP attenuated
IL-6 secretion compared with TSA-pretreated
controls, reaching significance at the lowest
(0.2 μM) ATP dose. This lowered IL-6 secre-
tion was not due to cell death because this was
overcome by 2 and 20 μM ATP. Next, we
determined the kinetics of ATP-mediated IL-6
secretion in THI-treated DCs to see if
cytokine production was attenuated at earlier
time points.
Figure 6B shows that 2 μM ATP induced
IL-6 by 4 hr, consistent with its rapid induc-
tion in other myeloid cells. THI pretreatment
accelerated IL-6 secretion compared with
TSA controls, indicating that THI sensitized
DCs to ATP. Maximal IL-6 was secreted by
THI-treated DCs by 8 hr, whereas controls
needed an additional 12 hr. A concentration
of 20 μM ATP was more potent than a 2 μM
concentration, eliciting IL-6 by 2 hr and
near-maximal levels at 8 hr in both THI- and
TSA-pretreated control IDCs (Figure 6C).
The strong accelerating effect of THI versus
TSA on IL-6 secretion induced by 2 μM ATP
was not as pronounced with 20 μM ATP,
generating a small but significant increase
4 hr after its application (Figure 6C).
Discussion
DC activation and associated immune func-
tions are subject to regulation by their redox
environment (Bagley et al. 2004; Gardella
et al. 2000; Goth et al. 2006; Murata et al.
2002; Novak et al. 2002). We generated DCs
under tightly regulated O2 and without 2-Me
to provide a more physiologic baseline to
study the mechanism of redox active environ-
mental triggers such as THI and EtHg in
regulating DC activation in vitro. For DCs,
Ca2+ signaling events provide an essential
“upstream” component, engaging immediate
events such as cytokine production and secre-
tion (Ferrari et al. 2000; la Sala et al. 2002)
and long-term (e.g., maturational) responses.
Importantly, microsomal IP3R and RyR Ca2+
Goth et al.
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Figure 5. Ry and THI functionally uncouple IP3R1 and RyR1 in IDCs. (A)C a 2+ transients elicited by ATP (20 µM, 5 sec) applied to IDCs that were preincubated either
with buffer (top trace), 100 µM Ry for 4 hr (second trace), 100 nM THI (5 min; third trace), or 100 µM Ry (4 hr) + 100 nM THI (5 min) (bottom trace). Traces are mean
responses ± SE and represent one of two experiments. (B–E) Statistics (mean ± SE) for time to peak (B), time to baseline (C), percent baseline elevation (D), and
percent ATP responders (E) derived from the cells shown in (A). Neither Ry nor THI alone or combined alter time to peak response toward 20 µM ATP (B).
However, Ry and/or THI signiﬁcantly shortened the recovery time to baseline (C), persistently elevated the recovery baseline for resting [Ca2+] (D), and recruited
more ATP-responsive DCs (E). Results were replicated in three independent experiments. 
*p < 0.05. **p < 0.01.
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channel functions are tightly regulated by
changes in local redox state (Bultynck et al.
2004; Kaplin et al. 1994; Pessah et al. 2002).
We show for the ﬁrst time the expression
and distribution of two major Ca2+ channel
proteins expressed in DCs. We have provided
transcriptomal and direct immunocyto-
chemical evidence that DCs express specific
isoforms of the IP3R and RyR Ca2+ channels.
RyR and IP3R proteins distinctly distribute in
DC subsets. In IDCs, RyR1 and IP3R1 local-
ize below the plasma membrane at the base of
the dendrites and into the processes. A similar
distribution of the RyR was seen in MDCs.
However IP3Rs extend to reticular regions
where the RyR1 is either absent or at very low
levels. In human monocytes, IP3R and RyR
localization patterns similar to our murine
DCs were found (Clark and Petty 2005).
ATP-triggered Ca2+ transients in IDCs
have three components that engage cross-talk
between IP3Rs and RyRs. The initial rate and
amplitude of the Ca2+ transient (phase 1;
Figure 7) is largely dependent upon IP3R acti-
vation. It is unlikely the RyR1 has a signifi-
cant influence on phase 1 because blocking
RyR1 channels with Ry has no measurable
consequence on these parameters. The tran-
sient decay rate depends on both IP3R and
RyR1 because blocking RyR1 channels with
Ry significantly enhances this rate back to
baseline (phase 2; Figure 7). Ca2+-induced
Ca2+ release, presumably mediated by activa-
tion of RyR1, must therefore contribute to
slowing the decay rate.
However, RyR1 activity in IDCs also con-
tributes to the negative regulation, reestablish-
ing a stable resting Ca2+ level near that before
activation of purinergic signaling (phase 3;
Figure 7). Phase 3 was unmasked when Ry or
THI modiﬁed RyR1 conformation. Phases 2
and 3 are coupled events that rely on the con-
formational state of the RyR1. In this regard,
both micromolar Ry and nanomolar THI
uncouple functional cross-talk between IP3R
and RyR1 channels normally regulating
purinergic signaling in IDCs.
Collectively, these data show that RyR1
channels are closely coupled to IP3-induced
Ca2+ release and contribute to the temporal
properties of the transient by prolonging the
decay and restoring the original resting Ca2+
level. RyR1 therefore contributes both positive
and negative regulation to purinergic signaling
in IDCs. THI, like Ry, appears to uncouple
RyR1 functions from phosphoinositide signal-
ing in IDCs in a concentration- and time-
dependent manner.
Nanomolar THI deregulated ATP-medi-
ated signaling by a mechanism that uncou-
pled phases 2 and 3 of the Ca2+ transient.
THI did not appear to influence the initial
response to ATP by activation of the IP3R
(phase 1) but enhanced the transient decay
rate after agonist withdrawal (phase 2) and
elicited a persistent rise in intracellular Ca2+
(phase 3). THI’s actions on IP3R-mediated
signals have not been previously explored in
DCs. However, evidence indicates that IP3R1
is a target of THI. Using triple-IP3R-knock-
out R23-11 cells derived from DT40 chicken
B lymphoma cells, THI (1–100 nM) poten-
tiated IP3-induced Ca2+ release when IP3R1,
but not IP3R3, is expressed (Bultynck et al.
2004).
RyR1 is also a sensitive target of THI
(Figure 3E) (Abramson et al. 1995). We show
that ATP triggers a Ca2+ transient in IDCs
whose temporal property relies on functional
coupling of IP3R and RyR1 channels that is
extremely sensitive to THI (≤ 100 nM). How
THI sensitizes RyR1 to activation by Ca2+
involves release of the inhibitory actions of
Mg2+, an important physiologic modulator
(Donoso et al. 2000; Sanchez et al. 2003) and
may be mediated by hyperreactive cysteines
within the RyR1 channel complex (Liu and
Pessah 1994; Voss et al. 2004). Exactly how
THI alters ATP-dependent and -independent
Ca2+ signals may involve multiple molecular
mechanisms involving the IP3R1, RyR1, and
possibly other channels. Nevertheless, the pre-
sent results reveal that IDCs are a particularly
sensitive target of THI, with as little as
50 nM within 30 min uncoupling ATP-
induced Ca2+ transients.
DC sensitivity to their oxidative environ-
ment may reflect how they generate and use
Ca2+ signals in response to a changing redox
environment. Redox modulation of DC func-
tion is underscored by our ﬁnding that THI
modulates IL-6 synthesis elicited by exogenous
ATP. Myeloid DC IL-6 strongly influences
mucosal T-cell and gut B-cell responses. Lung
DCs with intrinsic TH2-polarizing activities
generated TH1 responses from naive CD4+
T cells in the presence of anti–IL-6 neutraliz-
ing antibody (Dodge et al. 2003). Peyer’s
patch B cells were induced to secrete IgA by
IL-6 elaborated by local CD11b-positive DCs;
IgA induction was reduced by anti–IL-6 anti-
bodies (Sato et al. 2003).
In vivo ATP steady-state levels are at
nanomolar and low micromolar (1–25 μM)
Figure 6. THI suppression or exacerbation of ATP-mediated IL-6 secretion from IDCs is dependent on the ATP dose. (A) IL-6 accumulation induced by 0.2 µM ATP
is suppressed by 100 nM THI. Kinetics of IL-6 secretion induced by 2 µM ATP (B) or 20 µM ATP (C) is enhanced by 100 nM THI. DCs were pretreated with THI or
TSA as in (A). Data are means of quadruplicates ± SE. An independent cell culture was used for each graph.
*p > 0.05.
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Figure 7. Model showing how THI and Ry uncouple
regulation of Ca2+ transients elicited by ATP in IDCs.
The solid line depicts a typical Ca2+ transient trig-
gered by ATP in naive IDCs (Figure 4A). Under these
conditions, IP3R1 and RyR1 are functionally cou-
pled. The dashed line indicates observed changes
in the ATP-triggered Ca2+ transient after pre-
incubation with THI (100 nM, 5 min) or RyR1 channel
block (100 µM Ry, 4 hr). The rising phase of the tran-
sient (phase 1) remains unchanged by either THI or
Ry treatments (alone or combined) and is generated
by IP3R activation. Transient termination is signifi-
cantly faster after RyR1 modification by THI or Ry
(alone or combined; phase 2). Modiﬁed RyR1, IP3R1,
and/or Ca2+ entry may become “leaky,” resulting in
a persistent elevation in resting Ca2+ (phase 3).
Modiﬁcation of RyR1 conformation by either THI or
Ry is sufficient to uncouple phases 2 and 3 (see
“Discussion” for details).
C
a
2
+
 
r
e
s
p
o
n
s
e
Time
1
2
3concentrations in bulk fluids and at the cell
surface, respectively (Lazarowski et al. 2003).
At these concentrations, metabotropic G-pro-
tein–coupled P2Y receptors are engaged. In
THI-treated DCs, IL-6 production kinetics
are enhanced by 2 μM and 20 μM ATP, and
IL-6 secretion is significantly suppressed by
0.2 μM ATP (Figure 6A). THI-enhanced
IL-6 secretion may be a consequence of pro-
longed calcium signals resulting from the
uncoupling effects of THI toward IP3R- and
RyR1-mediated signals. Increased intracellu-
lar Ca2+ is associated with IL-6 RNA stabiliza-
tion and rapid IL-6 secretion (Bost and
Mason 1995). THI-mediated attenuation of
IL-6 secretion at 0.2 μM ATP was not unex-
pected because the suboptimal calcium signals
induced by 0.2 μM ATP may not have been
sufficient to promote maximal rates of IL-6
synthesis. Ca2+-stimulated RyR1 channels are
initially activated and then inactivated by
THI (Figure 3F) (Abramson et al. 1995).
Over the 20 hr assay used in this study, the
uncoupling of IP3R–RyR1 functions is likely
to have broad effects upon Ca2+-dependent
processes.
A practical implication of the present ﬁnd-
ings has relevance to the commercial uses of
THI as an antimicrobial agent in vaccines and
consumer products because they identify DCs
as sensitive targets for THI- and EtHg-medi-
ated dysfunction. Given the importance of
DCs as a front line in regulating lymphocyte-
mediated immunity and tolerance, altering DC
functions by forms of EtHg should be consid-
ered when assessing contributions to altered
immune function. In studies using the autoim-
mune-susceptible A.SW (H-2s) mouse strain,
THI induces a syndrome that is stronger and
more generally manifested than those pro-
duced by methylmercury (Havarinasab et al.
2004), and development of autoimmunity in
H-2s mice is dependent on cellular (T cell) and
soluble (IFN-γ and IL-6) factors (Havarinasab
et al. 2005). Onset of spontaneous systemic
autoimmune disease symptoms (proteinuria,
anti-DNA antibodies) in (NZBxNZW)F1
mice is hastened by THI (Havarinasab and
Hultman 2006). Interestingly, disease morbid-
ity and mortality in these F1 mice are dramati-
cally reduced by neutralizing anti–IL-6
receptor antibody (Mihara et al. 1998), an
effect associated with reduced IgG (auto-)
antibody production.
The human RyR1 gene is highly polymor-
phic. More than 60 single missense or dele-
tional mutations have been closely linked to
the pharmacogenetic disorders malignant
hyperthermia and central core disease
(Gronert et al. 2004). Our ﬁndings that DCs
primarily express the RyR1 channel complex
and that this complex is uncoupled by very
low levels of THI with dysregulated IL-6
secretion raise intriguing questions about a
molecular basis for immune dyregulation and
the possible role of the RyR1 complex in
genetic susceptibility of the immune system
to mercury.
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